Form 4 for CBIO CRESCENT BIOPHARMA, INC.
Accepted 2022-11-14 00:00:00 ET · period of report 2022-11-11 · accession 0001209191-22-056563 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-11-14 | 2022-11-11 | CBIO | Girard Armand | SVP, Chief Business Off | P - Purchase | $1.05 | +6,500 | 29.2K | +29% | +$6,825 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-11-11 | P | A | 6,500 | $1.05 | 29,161 | D | — | — |